Pharmaceutical Industry Association

What Pharmaceutical Industry Association does

Pharmaceutical Industry Association is a Milan-based private organization founded in 1960 that promotes cultural initiatives for the practical and scientific monitoring of the pharmaceutical sector. Stated headcount of 1,001–5,000 employees and a presence on the afiscientifica.it domain indicate a sizable institutional footprint within Italy, though the input does not specify membership structure, governance, or member services in any detail.

The association's activities extend beyond domestic Italian advocacy. In the GDUFA IV negotiation cycle covering fiscal years 2028–2032, it joined broader industry opposition to FDA proposals that would waive annual facility fees for new domestic generic-drug and API manufacturers and raise the foreign facility fee from $15,000 to $25,000 — evidence of cross-Atlantic regulatory engagement.

The business model, revenue mechanics, product surface, customer/member mix, and pricing details are not disclosed in the available data. No funding rounds, M&A activity, partnerships, certifications, technology stack, AI capabilities, or product launches are documented, so any characterization of monetization or growth dynamics is limited to the sectoral-advocacy role implied by the single regulatory action on record.

Name

Pharmaceutical Industry Association

Website

https://afiscientifica.it

Company type

Private

Founded year

1960

Headcount range

1,001–5,000 employees

Short description

Pharmaceutical Industry Association is a Milan-based, privately held sectoral body founded in 1960 that promotes cultural and scientific monitoring of the pharmaceutical industry and engages in cross-border regulatory advocacy on manufacturing policy.

Ownership category

akta.pro rank

Product category

Pharmaceutical Trade Association Services

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)

akta.pro secondary industries

Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI), Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Pharmaceutical industry association
• Pharmaceutical trade association
• Drug industry advocacy
• Pharmaceutical sector monitoring
• Industry regulatory representation

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

Pharmaceutical Industry Association promotes cultural initiatives for practical and scientific monitoring of the pharmaceutical sector, operating as a representative body for pharmaceutical companies. The association engages with industry regulatory matters, including publicly responding to proposed FDA facility fee frameworks and policy negotiations affecting the pharmaceutical supply chain.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• EFPIA (European Federation of Pharmaceutical Industries and Associations): Brussels-based pan-European pharma industry association. Comparable in advocacy and policy-monitoring mandate, but operates at EU-wide scale rather than Italy-only.
• Medicines for Europe: European generics and value-medicines industry association. Direct peer given the subject organization's engagement with FDA GDUFA, which governs generic-drug facility fees.
• EGA (European Generic medicines Association, now part of Medicines for Europe): Predecessor European generic-medicines industry body (merged into Medicines for Europe). Comparable in generic-drug regulatory advocacy, specifically relevant given subject's GDUFA IV positioning.
• Farmindustria: Italian pharmaceutical industry association representing manufacturers operating in Italy. Closest direct peer given shared Italian geography, manufacturer constituency, and advocacy mandate.

Broad incumbents

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Geneva-based global pharma industry association. Comparable as a scientific-monitoring and advocacy body, but with global rather than Italian scope.
• PhRMA (Pharmaceutical Research and Manufacturers of America): Largest US pharma industry association. Comparable in advocacy and regulatory engagement role (including on FDA policy like GDUFA), but operating at significantly larger scale and US-focused.
• BIO (Biotechnology Innovation Organization): US biotechnology industry association. Comparable advocacy and scientific-monitoring mandate, but focused on biotech rather than the broader pharma manufacturer base.

Regional players

• AESGP (Association of the European Self-Medication Industry): European consumer-healthcare industry association. Comparable as a pharma sub-sector advocacy body operating at EU level; not a direct competitor but serves overlapping Italian members.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/afiscientifica

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaceutical Industry Association